HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical and molecular cytogenetic characteristics of dic(9;20) in adult acute lymphoblastic leukemia: a case report of three patients.

Abstract
Dicentric (9;20) [dic(9;20)] is a rare recurring chromosome abnormality in leukemia patients. In this study, we report three adult patients with acute lymphoblastic leukemia (ALL) with dic(9;20) anomaly. All three patients were diagnosed as cluster of differentiation 10 (CD10) positive B cell ALL, achieved complete remission after induction chemotherapy, and died of leukemia relapse within 1 year after diagnosis. Specimens for chromosome analysis were prepared by direct method and/or short-time culture of bone marrow cells. Karyotyping was performed by R-banding technique. Dual-color fluorescence in situ hybridization (FISH) was performed using chromosome 9 and chromosome 20-specific centromeric probes. Karyotype analysis showed that all three patients had dic(9;20)(p11-13;q11), in which the dicentric nature of the derived chromosome was confirmed by interphase FISH. Dicentric (9;20)(p11-13;q11) may be specifically associated with ALL, and monosomy 20 may be a pointer to dic(9;20) in ALL. The prognostic significance of dic(9;20) in adult patients with ALL remains to be determined.
AuthorsXianmin Song, Shenglan Gong, Jianmin Yang, Jianmin Wang
JournalAnnals of hematology (Ann Hematol) Vol. 86 Issue 5 Pg. 347-51 (May 2007) ISSN: 0939-5555 [Print] Germany
PMID17245591 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Burkitt Lymphoma (genetics)
  • Chromosome Aberrations
  • Chromosomes, Human, Pair 20
  • Chromosomes, Human, Pair 9
  • Fatal Outcome
  • Female
  • Humans
  • In Situ Hybridization, Fluorescence
  • Male
  • Middle Aged
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (genetics)
  • Translocation, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: